CellPrint Biotechnology   Report issue

For profit Phase 4
Founded: Cleveland OH United States (2016)

Organization Overview

First Clinical Trial
2016
NCT02909504
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

lithium (lithonate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1